Alembic Pharmaceuticals Ltd. (APLLTD) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 807696, "name": "Alembic Pharma", "stock_name": "Alembic Pharma", "full_name": "Alembic Pharmaceuticals Ltd.", "name_url": "stocks-analysis/alembic-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "850.35", "chg": 4.65, "chgp": "0.55%", "dir": 1, "prev_price": "845.70", "mcapval": "16,843.00 Cr", "mcap": "Small Cap", "scripcode": 533573, "symbol": "APLLTD", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE901L01018", "curr_date": "Sep 21, 03:30 PM", "curr_time": "08:45 AM", "last_traded_at": "Sep 21, 03:30 PM IST", "bse_nse_vol": "2.57 lacs", "exc_status": "Active", "traded_date": "Sep 21, 2026", "traded_date_str": "2026 09 21", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alembic-pharma-807696-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Alembic Pharmaceuticals Ltd. is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/alembic-pharmaceuticals-ltd-is-rated-hold-by-marketsmojo-4194929", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AlembicPharmace_mojoScore_4194929.png", "date": "2026-09-16 10:10:36", "description": "Alembic Pharmaceuticals Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 September 2026, providing investors with an up-to-date view of the company’s performance and outlook." }, { "title": "Alembic Pharmaceuticals Ltd. is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/alembic-pharmaceuticals-ltd-is-rated-hold-by-marketsmojo-4183175", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AlembicPharmace_mojoScore_4183175.png", "date": "2026-09-05 10:10:29", "description": "Alembic Pharmaceuticals Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 September 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Alembic Pharmaceuticals Ltd. is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/alembic-pharmaceuticals-ltd-is-rated-hold-4168642", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlembicPharmace_mojoScore_4168642.png", "date": "2026-08-25 10:10:49", "description": "Alembic Pharmaceuticals Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 August 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Alembic Pharmaceuticals Gains 0.19%: 5 Key Factors Driving the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/alembic-pharmaceuticals-gains-019-5-key-factors-driving-the-week-4155673", "imagepath": "", "date": "2026-08-15 15:04:03", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>10 Aug:</strong> Stock opens at Rs.830.30 with minor gains amid stable market</p>\n <p><strong>11 Aug:</strong> Technical momentum shifts amid mixed indicator signals; stock rises 0.98% to Rs.838.45</p>\n <p><strong>13 Aug:</strong> Golden Cross formed as 50-day moving average crosses above 200-day; stock peaks at Rs.841.25</p>\n <p><strong>14 Aug:</strong> Rating upgraded to Hold by MarketsMOJO; stock closes at Rs.831.40 despite mild decline</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.829.65</div..." }, { "title": "Alembic Pharmaceuticals Ltd. Upgraded to Hold on Technical Improvements and Valuation Appeal", "link": "https://www.marketsmojo.com/news/stock-recommendation/alembic-pharmaceuticals-ltd-upgraded-to-hold-on-technical-improvements-and-valuation-appeal-4152970", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlembicPharmace_mojoScore_4152970.png", "date": "2026-08-14 08:21:44", "description": "Alembic Pharmaceuticals Ltd. has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across technical indicators, valuation metrics, and financial stability despite flat recent earnings. The company’s evolving technical trend and attractive valuation relative to peers underpin this reassessment, even as long-term growth challenges persist." }, { "title": "Alembic Pharmaceuticals Ltd. Technical Momentum Shifts Signal Mild Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/alembic-pharmaceuticals-ltd-technical-momentum-shifts-signal-mild-bullish-outlook-4152823", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlembicPharmace_technicaldot_4152823.png", "date": "2026-08-14 08:03:58", "description": "Alembic Pharmaceuticals Ltd. has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. Despite a modest day decline of 1.17%, the stock’s technical indicators reveal a complex interplay of bullish and bearish signals across different timeframes, suggesting cautious optimism for investors in the Pharmaceuticals & Biotechnology sector." }, { "title": "Alembic Pharmaceuticals Ltd. Forms Golden Cross Amid Mixed Technical Signals and Modest Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/alembic-pharmaceuticals-ltd-forms-golden-cross-signalling-potential-bullish-breakout-4152279", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlembicPharmace_goldencross_4152279.png", "date": "2026-08-13 18:20:13", "description": "The 50-day moving average for Alembic Pharmaceuticals Ltd. has crossed above the 200-day moving average, signalling a golden cross on 13 Aug 2026. Yet, the stock declined 1.17% on the day of the crossover, while monthly momentum indicators remain bearish. This divergence between the moving averages and other technical signals calls for a nuanced analysis of the signal’s reliability." }, { "title": "Alembic Pharmaceuticals Ltd. Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/alembic-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-market-signals-4151043", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlembicPharmace_technicaldot_4151043.png", "date": "2026-08-13 08:02:20", "description": "Alembic Pharmaceuticals Ltd. has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a modest day gain of 0.33%, the stock’s technical indicators present a nuanced picture that investors should carefully analyse amid broader market conditions." }, { "title": "Alembic Pharmaceuticals Ltd. is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/alembic-pharmaceuticals-ltd-is-rated-sell-4150023", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlembicPharmace_mojoScore_4150023.png", "date": "2026-08-12 10:11:22", "description": "Alembic Pharmaceuticals Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." } ], "total": 5327, "sid": "807696", "stock_news_url": "https://www.marketsmojo.com/news/alembic-pharmaceuticals-807696" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "18-Sep-2026", "details": "Please find enclosed Intimation of One to One Investor Meet.", "source": "BSE" }, { "caption": "Update On USFDA Inspection Conducted During 3Rd March 2025 To 7Th March 2025 At Bioequivalence Facility Located At Vadodara Gujarat.", "datetime": "16-Sep-2026", "details": "Update on USFDA inspection conducted during 3rd March 2025 to 7th March 2025 at Bioequivalence Facility located at Vadodara Gujarat.", "source": "BSE" }, { "caption": "Intimation Regarding Successful Completion Of Unannounced USFDA Onsite Bioequivalence Inspection.", "datetime": "11-Sep-2026", "details": "Successful completion of unannounced USFDA onsite inspection at Alembic Pharmaceuticals Limiteds Bioequivalence Facility in Vadodara Gujarat.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Alembic Pharmaceuticals Ltd. has declared <strong>600%</strong> dividend, ex-date: 29 Jul 26", "dt": "2026-07-29", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

10 Aug: Stock opens at Rs.830.30 with minor gains amid stable market

11 Aug: Technical momentum shifts amid mixed indicator signals; stock rises 0.98% to Rs.838.45

13 Aug: Golden Cross formed as 50-day moving average crosses above 200-day; stock peaks at Rs.841.25

14 Aug: Rating upgraded to Hold by MarketsMOJO; stock closes at Rs.831.40 despite mild decline

Week Open

Rs.829.65Read full news article

Alembic Pharmaceuticals Ltd. Upgraded to Hold on Technical Improvements and Valuation Appeal

2026-08-14 08:21:44

Alembic Pharmaceuticals Ltd. has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across technical indicators, valuation metrics, and financial stability despite flat recent earnings. The company’s evolving technical trend and attractive valuation relative to peers underpin this reassessment, even as long-term growth challenges persist.

Read full news article

Alembic Pharmaceuticals Ltd. Technical Momentum Shifts Signal Mild Bullish Outlook

2026-08-14 08:03:58

Alembic Pharmaceuticals Ltd. has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. Despite a modest day decline of 1.17%, the stock’s technical indicators reveal a complex interplay of bullish and bearish signals across different timeframes, suggesting cautious optimism for investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

Alembic Pharmaceuticals Ltd. Forms Golden Cross Amid Mixed Technical Signals and Modest Momentum

2026-08-13 18:20:13

The 50-day moving average for Alembic Pharmaceuticals Ltd. has crossed above the 200-day moving average, signalling a golden cross on 13 Aug 2026. Yet, the stock declined 1.17% on the day of the crossover, while monthly momentum indicators remain bearish. This divergence between the moving averages and other technical signals calls for a nuanced analysis of the signal’s reliability.

Read full news article

Alembic Pharmaceuticals Ltd. Technical Momentum Shifts Amid Mixed Market Signals

2026-08-13 08:02:20

Alembic Pharmaceuticals Ltd. has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a modest day gain of 0.33%, the stock’s technical indicators present a nuanced picture that investors should carefully analyse amid broader market conditions.

Read full news article

Alembic Pharmaceuticals Ltd. is Rated Sell

2026-08-12 10:11:22

Alembic Pharmaceuticals Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article